Treatment For Metastatic Hormone Sensitive Prostate Cancer (M - HSPC)
AUAUniversity3 Loka 2019

Treatment For Metastatic Hormone Sensitive Prostate Cancer (M - HSPC)

Co-Host: Kelvin Moses, MD At the conclusion of these activities, participants will be able to: 1. Identify the active agents and their mechanism of action in the management of metastatic HSPC. 2. Describe the risks and benefits of treatment for metastatic HSPC. CME Available: auau.auanet.org/node/26063 This educational series is supported by independent educational grants from: Amgen Astellas AstraZeneca Bristol-Myers Squibb Genomic Health Merck Pfizer, Inc. Sanofi Genzyme UroGen Pharma

Jaksot(421)

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
rss-narsisti
adhd-podi
rss-liian-kuuma-peruna
rss-niinku-asia-on
aamukahvilla
rss-valo-minussa-2
rss-koira-haudattuna
kesken
psykologia
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-vapaudu-voimaasi
rss-arkea-ja-aurinkoa-podcast-espanjasta
leveli
rss-luonnollinen-synnytys-podcast
aloita-meditaatio
jari-sarasvuo-podcast
rss-taloustaito-podcast